Literature DB >> 23903363

Giant thrombus on apical wall of left ventricle due to HIT syndrome after anterior MI.

U Y Sinan1, U Coskun, B Balaban Kocas, N Gultekin, T Gurmen, S Kucukoglu.   

Abstract

Heparin-induced thrombocytopenia (HIT) is the most important and the most frequent drug-induced, immune-mediated type of thrombocytopenia. It is associated with significant mortality and morbidity if unrecognized. We describe a patient with a giant thrombus on the apical wall of the left ventricle that occurred due to HIT syndrome after anterior myocardial infarction.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23903363     DOI： 10.1007/s00059-013-3908-x

Source DB:  PubMed          Journal:  Herz        ISSN： 0340-9937            Impact factor:   1.443


  12 in total

1.  Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings.

Authors:  G K Lo; D Juhl; T E Warkentin; C S Sigouin; P Eichler; A Greinacher
Journal:  J Thromb Haemost       Date:  2006-04       Impact factor: 5.824

2.  ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention).

Authors:  Sidney C Smith; Ted E Feldman; John W Hirshfeld; Alice K Jacobs; Morton J Kern; Spencer B King; Douglass A Morrison; William W O'Neill; Hartzell V Schaff; Patrick L Whitlow; David O Williams; Elliott M Antman; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2006-01-03       Impact factor: 29.690

3.  Immunogenic but effective: the HIT-fondaparinux brain puzzler.

Authors:  A Greinacher
Journal:  J Thromb Haemost       Date:  2011-12       Impact factor: 5.824

4.  [Myocardial infarction and massive biventricular thrombosis during thrombocytopenia induced by pentosan polysulfate and heparin].

Authors:  C Leclercq; C de Place; C Rioux; P Mabo; F Paillard; J C Daubert
Journal:  Arch Mal Coeur Vaiss       Date:  1990-01

5.  Successful treatment of heparin induced thrombocytopenia (HIT) with fondaparinux.

Authors:  Kevin H M Kuo; Michael J Kovacs
Journal:  Thromb Haemost       Date:  2005-05       Impact factor: 5.249

6.  Simple scoring system for early management of heparin-induced thrombocytopenia.

Authors:  Harry L Messmore; Nancy Fabbrini; Mary L Bird; Abdul M Choudhury; Miguel Cerejo; Margaret Prechel; Walter P Jeske; Arshea Siddiqui; Indermohan Thethi; William H Wehrmacher; Jeanine M Walenga
Journal:  Clin Appl Thromb Hemost       Date:  2010-12-15       Impact factor: 2.389

7.  Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia.

Authors:  D E Wallis; D L Workman; B E Lewis; L Steen; R Pifarre; J F Moran
Journal:  Am J Med       Date:  1999-06       Impact factor: 4.965

8.  Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.

Authors:  T E Warkentin; M N Levine; J Hirsh; P Horsewood; R S Roberts; M Gent; J G Kelton
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

Review 9.  Laboratory diagnosis of immune heparin-induced thrombocytopenia.

Authors:  Theodore E Warkentin; Nancy M Heddle
Journal:  Curr Hematol Rep       Date:  2003-03

10.  Heparin-induced thrombocytopenia: an update.

Authors:  Massimo Franchini
Journal:  Thromb J       Date:  2005-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.